Literature DB >> 16477479

Neuropsychology of multiple sclerosis--an overview.

Pasquale Calabrese1.   

Abstract

Neuropsychological dysfunctions have been well documented in patients with multiple sclerosis. We herein give an overview of the main findings of recent decades. The pros and cons of considering the cognitive deficits of multiple sclerosis patients as a form of 'subcortical dementia' are discussed. By comparing the neuropsychological descriptions of multiple sclerosis patients as given in the literature to other neurological diseases which are also associated with neuropsychological deficiencies, we propose the term 'multiple disconnection syndrome' to describe the variety of neuropsychological deficits encountered in this demyelinating disease. Furthermore, a ' threshold of cerebral tolerance' is assumed which must be crossed before cognitive dysfunctions are manifested clinically.

Entities:  

Mesh:

Year:  2006        PMID: 16477479     DOI: 10.1007/s00415-006-1103-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  45 in total

1.  Anterograde and retrograde amnesia in patients with chronic progressive multiple sclerosis.

Authors:  W W Beatty; D E Goodkin; N Monson; P A Beatty; D Hertsgaard
Journal:  Arch Neurol       Date:  1988-06

2.  Neuropsychological assessment in multiple sclerosis: a follow-up study with magnetic resonance imaging.

Authors:  C Mariani; E Farina; S F Cappa; G P Anzola; L Faglia; L Bevilacqua; R Capra; F Mattioli; L A Vignolo
Journal:  J Neurol       Date:  1991-10       Impact factor: 4.849

3.  Cognition in patients with multiple sclerosis After four years.

Authors:  A Jennekens-Schinkel; P M Laboyrie; J B Lanser; E A van der Velde
Journal:  J Neurol Sci       Date:  1990-11       Impact factor: 3.181

4.  Cognitive impairment in patients with multiple sclerosis and mild physical disability.

Authors:  W van den Burg; A H van Zomeren; J M Minderhoud; A J Prange; N S Meijer
Journal:  Arch Neurol       Date:  1987-05

5.  Studies on the natural history of multiple sclerosis. 6. Clinical and laboratory findings at first diagnosis.

Authors:  J F Kurtzke; G W Beebe; B Nagler; T L Auth; L T Kurland; M D Nefzger
Journal:  Acta Neurol Scand       Date:  1972       Impact factor: 3.209

6.  Magnetic resonance imaging correlates of dementia in multiple sclerosis.

Authors:  S J Huber; G W Paulson; E C Shuttleworth; D Chakeres; L E Clapp; A Pakalnis; K Weiss; K Rammohan
Journal:  Arch Neurol       Date:  1987-07

7.  The prevalence of cognitive impairment in a community survey of multiple sclerosis.

Authors:  S A McIntosh-Michaelis; M H Roberts; S M Wilkinson; I D Diamond; D L McLellan; J P Martin; A J Spackman
Journal:  Br J Clin Psychol       Date:  1991-11

8.  Reaction time deficit in multiple sclerosis.

Authors:  P Elsass; I Zeeberg
Journal:  Acta Neurol Scand       Date:  1983-10       Impact factor: 3.209

Review 9.  Cognitive loss in multiple sclerosis. Case reports and review of the literature.

Authors:  G M Franklin; L M Nelson; C M Filley; R K Heaton
Journal:  Arch Neurol       Date:  1989-02

10.  Neuropsychological performance in patients with mild multiple sclerosis.

Authors:  H Klonoff; C Clark; J Oger; D Paty; D Li
Journal:  J Nerv Ment Dis       Date:  1991-03       Impact factor: 2.254

View more
  26 in total

1.  Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment.

Authors:  Ida S Haussleiter; Martin Brüne; Georg Juckel
Journal:  Ther Adv Neurol Disord       Date:  2009-01       Impact factor: 6.570

2.  Neuropsychiatric manifestations of multiple sclerosis.

Authors:  Laura C Politte; Jeff C Huffman; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

3.  Group cognitive rehabilitation to reduce the psychological impact of multiple sclerosis on quality of life: the CRAMMS RCT.

Authors:  Nadina B Lincoln; Lucy E Bradshaw; Cris S Constantinescu; Florence Day; Avril Er Drummond; Deborah Fitzsimmons; Shaun Harris; Alan A Montgomery; Roshan das Nair
Journal:  Health Technol Assess       Date:  2020-01       Impact factor: 4.014

4.  Working memory impairment in calcineurin knock-out mice is associated with alterations in synaptic vesicle cycling and disruption of high-frequency synaptic and network activity in prefrontal cortex.

Authors:  Jeffrey R Cottrell; Jonathan M Levenson; Sung Hyun Kim; Helen E Gibson; Kristen A Richardson; Michael Sivula; Bing Li; Crystle J Ashford; Karen A Heindl; Ryan J Babcock; David M Rose; Chris M Hempel; Kjesten A Wiig; Pascal Laeng; Margaret E Levin; Timothy A Ryan; David J Gerber
Journal:  J Neurosci       Date:  2013-07-03       Impact factor: 6.167

5.  Whom to Target for Falls-Prevention Trials: Recommendations from the International MS Falls Prevention Research Network.

Authors:  Michelle Cameron; Susan Coote; Jacob J Sosnoff
Journal:  Int J MS Care       Date:  2014

6.  Interference Effect of Prior Explicit Information on Motor Sequence Learning in Relapsing-Remitting Multiple Sclerosis Patients.

Authors:  Nahid Zahiri; Iraj Abollahi; Seyed Massood Nabavi; Fatemeh Ehsani; Amir Masoud Arab; Ina Shaw; Ardalan Shariat; Brandon S Shaw; Maryam Dastoorpoor; Mahmoud Danaee; Bahram Sangelaji
Journal:  Malays J Med Sci       Date:  2017-02-24

7.  Communicating the diagnosis of multiple sclerosis: results of a survey among Greek neurologists.

Authors:  Panagiotis Papathanasopoulos; Lambros Messinis; Epameinondas Lyros; Anastasia Nikolakopoulou; Eftymia Gourzoulidou; Sonia Malefaki
Journal:  J Neurol       Date:  2008-12-20       Impact factor: 4.849

8.  Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis.

Authors:  R S Prakash; E M Snook; J M Lewis; R W Motl; A F Kramer
Journal:  Mult Scler       Date:  2008-08-13       Impact factor: 6.312

9.  The existence of phonatory instability in multiple sclerosis: an acoustic and electroglottographic study.

Authors:  Kostas Konstantopoulos; Michail Vikelis; John Anthony Seikel; Dimos-Dimitrios Mitsikostas
Journal:  Neurol Sci       Date:  2009-10-30       Impact factor: 3.307

Review 10.  Influences on cognition by immunosuppression and immunomodulation in multiple sclerosis.

Authors:  Hayrettin Tumani; Ingo Uttner
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.